Skip to content

Cilostazol 100 MG

DRUG17 trials

Sponsors

Genovate Biotechnology Co., Ltd.,, Henry Ford Health System, Ain Shams University, Kafrelsheikh University, Northern California Institute of Research and Education

Conditions

Aneurysmal Subarachnoid HemorrhageIntermittent ClaudicationIschemic StrokeMyocardial InfarctionRecurrent StrokeRheumatoid ArthritisStrokeStroke (CVA) or Transient Ischemic Attack

Phase 1

Phase 2

Phase 3

Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
RecruitingNCT06196047
Kafrelsheikh UniversityIschemic Stroke
Start: 2023-12-01End: 2024-12-30Target: 900Updated: 2024-08-20
Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke
RecruitingNCT06202755
Kafrelsheikh UniversityIschemic Stroke
Start: 2024-03-30End: 2025-07-12Target: 580Updated: 2024-08-20
Clopidogrel Versus Cilostazol in Ischemic Stroke
CompletedNCT06242132
Kafrelsheikh UniversityIschemic Stroke
Start: 2022-06-01End: 2024-08-01Updated: 2024-09-19
Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke
CompletedNCT06242145
Kafrelsheikh UniversityIschemic Stroke
Start: 2023-01-01End: 2024-08-01Updated: 2024-08-20
Ticagrelor Versus Cilostazol in Ischemic Stroke
RecruitingNCT06561867
Kafrelsheikh UniversityIschemic Stroke
Start: 2024-08-30End: 2025-12-20Target: 900Updated: 2024-08-20
Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA
RecruitingNCT06591377
Kafrelsheikh UniversityIschemic Stroke
Start: 2024-08-10End: 2025-10-01Target: 900Updated: 2025-09-18
Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA
RecruitingNCT06591390
Kafrelsheikh UniversityIschemic Stroke
Start: 2022-02-09End: 2024-10-01Target: 900Updated: 2024-09-19
Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA
RecruitingNCT06591351
Kafrelsheikh UniversityIschemic Stroke
Start: 2022-05-01End: 2024-10-10Target: 870Updated: 2024-09-19
Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA
RecruitingNCT06591299
Kafrelsheikh UniversityIschemic Stroke
Start: 2022-04-15End: 2024-09-30Target: 870Updated: 2024-09-19
Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication
TerminatedNCT06886620
Genovate Biotechnology Co., Ltd.,Intermittent Claudication
Start: 2016-03-14End: 2017-02-08Updated: 2025-03-20
CiLostAzol for pReventIon of Recurrent sTroke in Africa
Not yet recruitingNCT06919835
Northern California Institute of Research and EducationStroke
Start: 2025-12-01End: 2027-12-31Target: 1100Updated: 2025-10-03
Cilostazol for Prevention of Recurrent Stroke Trial
Not yet recruitingNCT07174414
Stanford UniversityIschemic Stroke, Myocardial Infarction, Recurrent Stroke +4
Start: 2026-08-31End: 2031-07-31Target: 2000Updated: 2025-09-16

Phase 4

Related Papers